Detecting and excluding coronavirus disease 2019 (COVID-19) at the point of need


  • Dr Joe Fitchett

    Mologic Ltd, United Kingdom

  • Dr Emily Adams

    Liverpool School of Tropical Medicine, United Kingdom

  • Prof Luis Cuevas

    Liverpool School of Tropical Medicine, United Kingdom

  • Prof Sanjeev Krishna

    St George's, University of London, United Kingdom

  • Dr Amadou Sall

    Institut Pasteur de Dakar, Senegal

Project summary

Rapid diagnostics have been identified by the WHO R&D Blueprint as a critical unmet need for the control of COVID-19 – particularly in the absence of a vaccine and proven antiviral agents. Our primary objective is to develop a low cost, high performance rapid test for the detection and exclusion of SARS-CoV-2, the causative virus of coronavirus disease 2019 (COVID-19).

The technology will be made available in line with the Global Access Policy for Gavi-eligible countries that are most vulnerable to onward transmission of COVID-19 and of limited detection due to insufficient laboratory capacity. The RDT will be appropriate for assembly and manufacture with multiple quality-assured partners to meet demand.